Provided by Tiger Fintech (Singapore) Pte. Ltd.

Teva Pharmaceutical

17.77
+0.52003.01%
Post-market: 17.70-0.0700-0.39%19:57 EDT
Volume:11.58M
Turnover:204.00M
Market Cap:20.38B
PE:-15.55
High:17.83
Open:17.58
Low:17.34
Close:17.25
Loading ...
Jan 25, 2021

Major Issues Report

8-K - Current report
Nov 05, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2020

Major Issues Report

8-K - Current report
Aug 13, 2020

Correspondence

CORRESP [Cover] - Correspondence
Aug 13, 2020

Correspondence

CORRESP [Cover] - Correspondence
Aug 06, 2020

Major Issues Report

8-K - Current report
Aug 05, 2020

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Aug 05, 2020

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Aug 05, 2020

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Aug 05, 2020

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Aug 05, 2020

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Aug 05, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Aug 05, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2020

Major Issues Report

8-K - Current report
Jun 19, 2020

Correspondence

CORRESP [Cover] - Correspondence
Jun 09, 2020

Major Issues Report

8-K - Current report
May 07, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2020

Major Issues Report

8-K - Current report
Feb 21, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals